CIK 0001802768
- Large accelerated filer
Royalty Pharma plc
Sign in to watch- Ticker
- RPRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- Operating
- Phone
- +1 212-883-0200
- Business address
- 110 EAST 59TH STREET, NEW YORK, NY, 10022
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $32,573,345
- in 6 filings, $32.6M under 10b5-1 plans
Net −$32,573,345. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 15 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-05 | HODGSON DAVID C Director | Grant or award | +4,545 | 37,873 | ||
| 2025-05-13 | HODGSON DAVID C Director | Grant or award | +7,614 | 33,328 | ||
| 2024-06-07 | HODGSON DAVID C Director | Grant or award | +9,293 | 25,714 | ||
| 2023-06-23 | HODGSON DAVID C Director | Grant or award | +7,747 | 16,421 | ||
| 2022-07-08 | HODGSON DAVID C Director | Grant or award | +2,346 | 8,674 | ||
| 2022-06-24 | HODGSON DAVID C Director | Grant or award | +6,328 | 6,328 |
Page 1 of 1 · 6 trades